Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas de Prost

Showing results (251-260 of 267) with videos related to

Pageof 27
Sort By:
Intensive Care Medicine Experimental|August 6, 2023
Clinical phenotypes and outcomes associated with SARS-CoV-2 Omicron variants BA.2, BA.5 and BQ.1.1 in critically ill patients with COVID-19: a prospective, multicenter cohort studyNicolas de Prost, Etienne Audureau, Sébastien Préau, et al.
Trials|December 18, 2019
The Artificial Kidney Initiation in Kidney Injury 2 (AKIKI2): study protocol for a randomized controlled trialStéphane Gaudry, David Hajage, Laurent Martin-Lefevre, et al.
Intensive Care Medicine|October 27, 2019
Severe leptospirosis in non-tropical areas: a nationwide, multicentre, retrospective study in French ICUsArnaud-Félix Miailhe, Emmanuelle Mercier, Adel Maamar, et al.
Lancet (London, England)|April 4, 2021
Comparison of two delayed strategies for renal replacement therapy initiation for severe acute kidney injury (AKIKI 2): a multicentre, open-label, randomised, controlled trialStéphane Gaudry, David Hajage, Laurent Martin-Lefevre, et al.
Intensive Care Medicine|January 31, 2018
Decreased susceptibility to chlorhexidine affects a quarter of Escherichia coli isolates responsible for pneumonia in ICU patientsBéatrice La Combe, Alexandre Bleibtreu, Jonathan Messika, et al.
Nature Communications|December 8, 2022
Author Correction: Clinical phenotypes and outcomes associated with SARS-CoV-2 variant Omicron in critically ill French patients with COVID-19Nicolas de Prost, Etienne Audureau, Nicholas Heming, et al.
Intensive Care Medicine|February 26, 2024
Renal replacement therapy initiation strategies in comatose patients with severe acute kidney injury: a secondary analysis of a multicenter randomized controlled trialThomas Rambaud, David Hajage, Didier Dreyfuss, et al.
Nature Communications|October 12, 2022
Clinical phenotypes and outcomes associated with SARS-CoV-2 variant Omicron in critically ill French patients with COVID-19Nicolas de Prost, Etienne Audureau, Nicholas Heming, et al.
The Journal of Experimental Medicine|December 16, 2024
A common form of dominant human IFNAR1 deficiency impairs IFN-α and -ω but not IFN-β-dependent immunityFahd Al Qureshah, Jérémie Le Pen, Nicole A de Weerd, et al.
Critical Care (London, England)|July 22, 2025
Characteristics and outcomes of ICU patients with sepsis transmitted by cats and dogs: the PETSEPSIS multicentre retrospective observational cohort studyJuliette Quintin, Aurélie Le Thuaut, Fabienne Plouvier, et al.
Pageof 27

Showing results (251-260 of 267) with videos related to

Sort By:
Pageof 27
Intensive Care Medicine Experimental|August 6, 2023
Clinical phenotypes and outcomes associated with SARS-CoV-2 Omicron variants BA.2, BA.5 and BQ.1.1 in critically ill patients with COVID-19: a prospective, multicenter cohort studyNicolas de Prost, Etienne Audureau, Sébastien Préau, et al.
Trials|December 18, 2019
The Artificial Kidney Initiation in Kidney Injury 2 (AKIKI2): study protocol for a randomized controlled trialStéphane Gaudry, David Hajage, Laurent Martin-Lefevre, et al.
Intensive Care Medicine|October 27, 2019
Severe leptospirosis in non-tropical areas: a nationwide, multicentre, retrospective study in French ICUsArnaud-Félix Miailhe, Emmanuelle Mercier, Adel Maamar, et al.
Lancet (London, England)|April 4, 2021
Comparison of two delayed strategies for renal replacement therapy initiation for severe acute kidney injury (AKIKI 2): a multicentre, open-label, randomised, controlled trialStéphane Gaudry, David Hajage, Laurent Martin-Lefevre, et al.
Intensive Care Medicine|January 31, 2018
Decreased susceptibility to chlorhexidine affects a quarter of Escherichia coli isolates responsible for pneumonia in ICU patientsBéatrice La Combe, Alexandre Bleibtreu, Jonathan Messika, et al.
Nature Communications|December 8, 2022
Author Correction: Clinical phenotypes and outcomes associated with SARS-CoV-2 variant Omicron in critically ill French patients with COVID-19Nicolas de Prost, Etienne Audureau, Nicholas Heming, et al.
Intensive Care Medicine|February 26, 2024
Renal replacement therapy initiation strategies in comatose patients with severe acute kidney injury: a secondary analysis of a multicenter randomized controlled trialThomas Rambaud, David Hajage, Didier Dreyfuss, et al.
Nature Communications|October 12, 2022
Clinical phenotypes and outcomes associated with SARS-CoV-2 variant Omicron in critically ill French patients with COVID-19Nicolas de Prost, Etienne Audureau, Nicholas Heming, et al.
The Journal of Experimental Medicine|December 16, 2024
A common form of dominant human IFNAR1 deficiency impairs IFN-α and -ω but not IFN-β-dependent immunityFahd Al Qureshah, Jérémie Le Pen, Nicole A de Weerd, et al.
Critical Care (London, England)|July 22, 2025
Characteristics and outcomes of ICU patients with sepsis transmitted by cats and dogs: the PETSEPSIS multicentre retrospective observational cohort studyJuliette Quintin, Aurélie Le Thuaut, Fabienne Plouvier, et al.
Pageof 27